MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going

SIMPLE SUMMARY: The problem of drug resistance represents a major challenge for the cure of non-small cell lung cancer. Tumor cells can be intrinsically resistant to drugs or they can become resistant during the treatment as a result of several adaptive responses. However, molecular mechanisms at th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuttano, Roberto, Afanga, Miriam Kuku, Bianchi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740066/
https://www.ncbi.nlm.nih.gov/pubmed/36497213
http://dx.doi.org/10.3390/cancers14235731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740066/
https://www.ncbi.nlm.nih.gov/pubmed/36497213
http://dx.doi.org/10.3390/cancers14235731

Ejemplares similares